DEPLOYDatabase

Company

Myomo

Myomo is a medical robotics company developing powered upper-limb orthoses and exoskeletons for stroke and neurological rehabilitation, including the MyoPro…

Founded
2004
HQ
Boston, Massachusetts, USA
Status
public (NYSE American: MYO)

The verified answer

As of Aug 2026, DEPLOY verifies Myomo: 1 model, 2 deployments across 2 regions. 2 sources back the record.

CategoryExoskeletons

Deploy Watch

Track Myomo on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Regional ecosystem

Myomo is one of 82 verified robotics companies in Massachusetts

Key facts

Robot

MyoPro is a myoelectric (EMG-controlled) powered arm brace for people with arm/hand paralysis.

Focus

Powered upper-limb orthotics for paralysis patients.

Origin

MIT spinout.

Founded

2004

Product

MyoPro 2+ powered upper-limb orthosis

Listed on

NYSE American: MYO

Application

Upper-limb paralysis, stroke rehabilitation

Data & sources

Web sources

2

2 sources backing this record.View all →

Partnerships

Every company Myomo has built with, alongside the ones only announced in a press release.

3 total2 operating1 just announced

Most-frequent partners

  1. 1AWS1× joint976 total
  2. 2Hobbs Rehabilitation1× joint
  3. 3NVIDIA1× joint1108 total

Most recent

Myomo on the deployment map

View the global map

2 verified deployments across 2 regions, newest verified Jun 2024. Explore where Myomo's robots are operating, by place and type.

Free to use on your site, with a link back to DEPLOY.

View the full Myomo deployment record →

Free to use on your site, with a link back to DEPLOY.

Relationships

Current leadership (1)

Safety record

No incidents on record for Myomo.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Operator customers (1)

Recent coverage

Myomo in third-party press

Peers

26 peers across 1 segment. Every Myomo competitor derived from shared form-factor and application-domain edges.

exoskeleton(26)

23 companies in this segment · highly_concentrated (HHI 5009.45179584121) · leader Hypershell at 5217%